Realize safe, scalable, and compliant cell therapies by building analytical strategies that exceed regulatory expectations.
This is part one of a two-part article offering proposals to improve the FDA’s guidance to implement a new approval framework for individualized genetic therapies based on a “plausible mechanism” of ...
While traces of HIV-1 RNA can persist in blood after optimal therapy for #HIV, cases of non-suppressible viremia (#NSV) are ...